اگلا

آٹو پلے

Treatment With Eribulin Mesylate in Metastatic Breast Cancer

4 مناظر • 07/03/23
بانٹیں
ایمبیڈ
administrator
administrator
سبسکرائبرز
0

In this segment, panelists explore the cytotoxic agent eribulin mesylate, which has been the focus of several recent clinical trials. In all, despite a growing focus on targeted therapies, cytotoxics remain an important class of drugs in the treatment of patients with metastatic breast cancer.

To view more from this discussion, visit http://www.onclive.com/peer-ex....change/MBC-challenge

مزید دکھائیں
0 تبصرے sort ترتیب دیں
فیس بک کے تبصرے

اگلا

آٹو پلے